Structure and Governance

Audit Committee Board of Directors CQDM (Management) Executive Committee Corporate Governance and Nominating Committee Strategic Orientation Committee Explore Advisory Committee

Board of Directors

Chairman

Léon Gosselin Léon Gosselin
Co-founder of Axcan Pharma

Members

Jennifer Chan
Vice President, Policy and Communications, Merck Canada

Richard Fajzel
General Manager, Oncolgy Business Unit, Pfizer Canada

Max Fehlmann
President and Chief Executive Officer, NeoMed Institute

Diane Gosselin
President and Chief Executive Officer, CQDM

Raphael Hofstein
President and Chief Executive Officer, MaRS Innovation

Rav Kumar
Vice-President, R&D Operations/Business Development, GSK Canada

Vassilios Papadopoulos
Director, Research Institute of the McGill University Health Center (MUHC)

Ken Pastor
General Partner, CTI Capital

Louise Proulx 
Chief Development Officer, Therillia

Marc Zarenda
Scientific Director, AstraZeneca Canada

Honorary Members

Elaine Campbell
President, AstraZeneca Canada

John Helou
President, Pfizer Canada

Remi Quirion
Chief Scientist, Fonds de recherche du Québec

Observers

Marco Blouin
Director - Industrial research, Ministère de l'Économie, de l'Innovation et des Exportations

Réginald Thériault
Program Deputy Director, Networks of Centres of Excellence

Secretary

François Painchaud 
Lawyer, Partner, ROBIC, LLP


Executive Committee

Chairman

Léon Gosselin Léon Gosselin
Co-founder of Axcan Pharma

Members

Jennifer Chan
Vice President, Policy and Communications, Merck Canada

Richard Fajzel
General Manager, Oncology Business Unit, Pfizer Canada

Diane Gosselin
President and Chief Executive Officer, CQDM

Vassilios Papadopoulos
Director, Research Institute of the McGill University Health Center (MUHC)


Audit Committee

Chairman

Ken Pastor
General Partner, CTI Capital

Member

Richard Fajzel
General Manager, Oncology Business Unit, Pfizer Canada


Corporate Governance and Nominating Committee

Chairman

Léon Gosselin Léon Gosselin
Co-founder of Axcan Pharma

Members

Jennifer Chan
Vice President, Policy and Communications, Merck Canada

Richard Fajzel
General Manager, Oncology Business Unit, Pfizer Canada

Diane Gosselin
President and Chief Executive Officer, CQDM

Raphael Hofstein
President and Chief Executive Officer, MaRS Innovation


Strategic Orientation Committee

Chairman

Steven Xanthoudakis
Director, Business Development & Licensing, Merck Canada

Members

André Darveau
Dean, Faculty of Sciences and Engineering, Université Laval

Peter Doig
Associate Director, Innovative Medicines - Discovery Sciences, AstraZeneca R&D UK

Terry Fetterhoff
Senior Director, Technology Management - Diagnostics Division, F. Hoffman-La Roche Ltd

H. Christian Fibiger
Assistant Dean, Research, Faculty of Medicine, University of British Columbia

Diane Gosselin
President and Chief Executive Officer, CQDM

Daniel Hétu
Managing Director, Lumira Capital

Mark Lim
Associate Director , Medical Research Innovation, FasterCures, USA

Patrice Roy
Regional Director, Medical Affairs, Pfizer Canada

Observers

Yvon Fréchette
Acting Coordinator, Direction de la recherche et de l'innovation universitaires, Ministère de l'Économie, de l'Innovation et des Exportations (MEIE)

Agnes Klein
Director, Centre for the Evaluation of Radiopharmaceuticals and Biotherapeutics, Health Canada

Réginald Thériault
Program Deputy Director, Networks of Centres of Excellence


Explore Advisory Committee

Chairman

Patrice Roy
Regional Director, Medical Affairs, Pfizer Canada

Members

George De Sanctis
Director, Partnering and Innovation, Sanofi United States

Peter Doig
Associate Director, Innovative Medicines - Discovery Sciences, AstraZeneca R&D UK

Jean Godin
Vice President, Chief Scientific Officer, Novartis Canada

Diane Gosselin
President and CEO, CQDM

Cyrille Kuhn
Executive Director, Research Networking & Strategic Planning, Boehringer Ingelheim Pharmaceuticals, USA

Jennifer Laird
Director, Global External Research and Development, Eli Lilly Canada

Amyn Sayani
Director, R&D Alliances, GSK Canada

Steven Xanthoudakis
Director, Business Development & Licensing, Merck Canada